Rufinamide Suspension
Product Images NDC 72205-038

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Rufinamide (NDC 72205-038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rufi-suspn-bottle-label (Rufi Suspn Bottle Label)

Rufinamide Oral Suspension 40 mg/mL label showing a 460 mL bottle. The label includes dosing information, storage instructions, warnings, and manufacturer details. It is manufactured by MSN Pharmaceuticals Inc. and distributed by Novadoz Pharmaceuticals LLC, both located in Piscataway, NJ. NDC 72205-038-77 is shown.*

FDA Label Image

Rufi-suspn-carton-label (Rufi Suspn Carton Label)

Rufinamide Oral Suspension 40 mg/mL label and carton packaging for oral administration. The product comes in a 460 mL oral suspension liquid supplied with two 20 mL oral syringes. Manufactured by MSN Pharmaceuticals Inc. and distributed by Novadoz Pharmaceuticals LLC. The label includes dosage instructions, storage conditions, and a warning to keep out of reach of children.*

FDA Label Image

Rufi-suspn-figure-a (Rufi Suspn Figure A)

Illustration showing components included with Rufinamide 40 mg/mL oral suspension: a bottle, a box, a bottle adapter, and two syringes. The diagram is labeled as Figure A and identifies each component visually.*

FDA Label Image

Rufi-suspn-figure-b (Rufi Suspn Figure B)

An instructional diagram labeled Figure B showing a hand holding a bottle, demonstrating the motion to shake the bottle well. The illustration emphasizes proper mixing of the contents before use.*

FDA Label Image

Rufi-suspn-figure-c (Rufi Suspn Figure C)

Illustration labeled Figure C showing a bottle adapter, a small component designed to fit onto a bottle, presumably for administering Rufinamide oral suspension.*

FDA Label Image

Rufi-suspn-figure-d (Rufi Suspn Figure D)

An instructional illustration showing a hand holding an oral suspension bottle with an arrow indicating the direction to press down or push the cap, likely demonstrating how to open or close the bottle cap for Rufinamide 40 mg/mL oral suspension.*

FDA Label Image

Rufi-suspn-figure-e (Rufi Suspn Figure E)

Illustration showing a syringe-style measuring device filled with a purple liquid, marked with volume graduations from 2 mL to 20 mL. A magnified inset highlights detailed graduation marks between 14 mL and 20 mL. The plunger is labeled at the bottom of the syringe.*

FDA Label Image

Rufi-suspn-figure-f (Rufi Suspn Figure F)

An instructional diagram showing a hand using a syringe to withdraw liquid from a bottle. The syringe is positioned above the bottle opening with a downward arrow indicating the direction for insertion or liquid extraction. No text other than 'Figure F' is visible.*

FDA Label Image

Rufi-suspn-figure-g (Rufi Suspn Figure G)

An instructional illustration showing a hand holding a syringe-like device filled with a purple liquid, positioned above an open container or mouth, with an arrow indicating downward movement. This likely demonstrates the proper way to administer Rufinamide oral suspension using the measuring device provided.*

FDA Label Image

Rufi-suspn-figure-h (Rufi Suspn Figure H)

Illustration showing how to measure Rufinamide oral suspension using a syringe. It instructs to measure liquid to the purple end of the plunger, with volume markings in milliliters visible on the syringe up to 10 mL.*

FDA Label Image

Rufi-suspn-figure-i (Rufi Suspn Figure I)

An instructional illustration showing a person administering oral suspension using a purple oral dosing syringe. The syringe is positioned near the person's open mouth for dosage delivery.*

FDA Label Image

Rufi-suspn-figure-j (Rufi Suspn Figure J)

An instructional illustration showing two steps of using a dosing syringe for oral suspension. The left panel depicts drawing liquid into the syringe from a cup, and the right panel shows pushing the liquid out by pressing the syringe plunger downward.*

FDA Label Image

Rufi-suspn-figure-k (Rufi Suspn Figure K)

An instructional illustration showing a hand turning the cap of a bottle, likely demonstrating how to open or close the bottle cap for a liquid medication container, such as a suspension.*

FDA Label Image

Rufi-suspn-structure (Rufi Suspn Structure)

Chemical structure of the active ingredient Rufinamide, showing its molecular framework including fluorine atoms, nitrogen-containing rings, and an amide group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.